Literature DB >> 13679075

Comparative transductions of breast cancer cells by three DNA viruses.

Annick Lucas1, Eric J Kremer, Silvio Hemmi, José Luis, Françoise Vignon, Gwendal Lazennec.   

Abstract

Defining the ideal vectors to transduce breast cancer using viruses is currently under intense pre-clinical evaluation. Our study constitutes the first direct comparison of the infection efficiencies of a human serotype 5 (Ad5), a canine serotype 2 (CAV-2) adenovirus, and a human serotype 2 adeno-associated virus (AAV-2) in breast cancer cells. We observed an excellent infection efficiency for Ad5 vector, whereas both CAV-2 and AAV-2 vectors lead to low infection of these cells. Real-time PCR, flow cytometry, and antibody blocking studies suggest that Ad5 and CAV-2 infection ability is not strictly dependent on coxsackie adenovirus receptor (CAR) or alpha(v) integrin levels. In conclusion, our data suggest that human adenoviruses are excellent transducers of breast cancer cells, though it may be difficult to predict the extent of infection solely on CAR or alpha(v) integrin levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679075     DOI: 10.1016/j.bbrc.2003.08.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy.

Authors:  Bernd Koppold; Georg Sauer; Hildegard Buening; Michael Hallek; Rolf Kreienberg; Helmut Deissler; Christian Kurzeder
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-23       Impact factor: 4.553

2.  A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.

Authors:  T Ranki; A Kanerva; A Ristimäki; T Hakkarainen; M Särkioja; L Kangasniemi; M Raki; P Laakkonen; S Goodison; A Hemminki
Journal:  Gene Ther       Date:  2006-08-10       Impact factor: 5.250

3.  Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer.

Authors:  Carine Bossard; Muriel Busson; David Vindrieux; Françoise Gaudin; Véronique Machelon; Madly Brigitte; Carine Jacquard; Arnaud Pillon; Patrick Balaguer; Karl Balabanian; Gwendal Lazennec
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

4.  Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids.

Authors:  Tobias Killian; Annette Buntz; Teresa Herlet; Heike Seul; Olaf Mundigl; Gernot Längst; Ulrich Brinkmann
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

5.  IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.

Authors:  Pauline Escobar; Céline Bouclier; Julien Serret; Ivan Bièche; Madly Brigitte; Andres Caicedo; Elodie Sanchez; Sophie Vacher; Marie-Luce Vignais; Philippe Bourin; David Geneviève; Franck Molina; Christian Jorgensen; Gwendal Lazennec
Journal:  Oncotarget       Date:  2015-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.